Today’s AI Top Pick: PDD
7/7/2026 · Recently Alerted GARP screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live PDD price forecast →
PDD is the cleanest setup in the pool right now: it combines top-tier fundamentals with multi-timeframe forecast agreement AND it isn't stretched. Fundamentals are elite for a screen this cheap — fwdPe 6.81, PEG 0.60, profit margin 21.86%, ROE 25.52%, sales growth 11.69%, EPS Next Y 20.39%, debt/eq 0.01, and a market cap of $119B means it's liquid enough to trade in size. Fundamental_score is a full 8 and bullish_prob is 1.0. The tape confirms without begging you to chase. Near_term_bullish is 1.0 (highest tier). Every forecast horizon that matters is green: 1h fc_mid +12.52 / long +21.78; 4h fc_mid +34.86 / long +22.29; 1d fc_short +15.12, mid +21.43, long +26.19; 1wk fc_short +11.30, mid +31.72, long +16.81. Four-timeframe forecast agreement to the upside is the 'gold' setup the brief asks for, and PDD is the only fully-covered name that delivers it. Positioning is favorable — 1d pos_in_21bar_range 82.24 with only -2.46% drawdown (buying strength, not top-tick), and 1wk pos is just 22.65% meaning the weekly base is still in accumulation, not distribution. News is a non-issue: Zacks/Yahoo attention flow is neutral-to-slightly-positive with Daiwa at Hold — no guidance cuts, no legal overhang, no dilution. Compare that to the other top-fundamental names where headlines actively disqualify them: FUTU has a DOJ probe and class actions (7/3), PODD has a serious-classified FDA Omnipod recall (7/6), CRK just got a Goldman Sell with a $10 PT. PDD is clean. Why TODAY vs. waiting: the weekly is still down 20.93% from the 21-bar high but the daily and intraday have already turned — this is the exact 'weekly base + daily inflection' pattern. Waiting for a deeper pullback risks missing the mid-term 21-26% forecast move. The 4h drawdown is only 1.52% — the pullback already happened intraday and the tape is re-accelerating.
- China ADR / geopolitical tape risk — a single tariff or delisting headline can slice 8-12% in a session regardless of fundamentals
- Temu-related regulatory scrutiny (de minimis exemption changes) remains an overhang on the US-facing growth story
- Weekly still shows -20.93% drawdown from 21-bar high and pos_in_range only 22.65% — the primary weekly trend is not yet confirmed up
- Analyst tape softened recently (Daiwa moved to Hold 7/1), recom is a lukewarm 1.93, so no near-term upgrade catalyst is priced in
- Sales growth 11.69% is the LOWEST among China peers in the pool — deceleration risk if next print disappoints
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | PDD | BUY NOW | 8.8 | Only name with all four timeframes forecast-green, mid-range positioning, elite valuation (fwdPe 6.81), and clean news. |
| 2 | ORCL | BUY NOW | 8.2 | Deep-value oversold bounce: RSI 30, 1d forecasts +21/+28/+26%, analysts upgrading after -35% June rout. |
| 3 | ADMA | BUY PULLBACK | 7.8 | Highest forecast magnitudes (1d long +72%) with 43% ROE, but at pos_in_range 100 on 3 timeframes — wait for pullback. |
| 4 | NAGE | BUY PULLBACK | 7.5 | Outsized 1d fc_short +92.6% and 242.9% targetUpside, but micro-cap ($278M) and weekly -30.83% dd — size accordingly. |
| 5 | PFSI | BUY NOW | 7.4 | fwdPe 5.99, PEG 0.32, 1d fc +12/+21/+15%, mid-range 45.62% — quiet, well-priced entry. |
| 6 | ESTC | BUY NOW | 7.3 | PEG 0.65, 4h fc_long +36%, 1wk fc_mid +62.53%; Rosenblatt Buy reiterated. |
| 7 | HURN | BUY NOW | 7.2 | Recom 1.00 (unanimous buy), targetUpside 84.2%, 1d fc_mid +28.96%, 1d pos 48% — solid entry, minor insider sale is noise. |
| 8 | BILI | BUY NOW | 7.0 | $300M buyback announced 6/24, 1d fc +20/+35/+8%, 1wk fc_mid +109%, weekly deeply oversold at pos 7.45%. |
| 9 | SE | BUY PULLBACK | 6.9 | Great business but 1h/4h/1d all pos_in_range >99, RSI 69.33 — wait for a pullback near $95. |
| 10 | HSAI | BUY PULLBACK | 6.7 | 44% sales growth, 1d fc +36/+22/+9%, but bullish_prob only 0.4 and weekly dd -37.79%. |
| 11 | DCBO | BUY NOW | 6.6 | ROE 132.85, PEG 0.45, 1d fc_mid +27.75%; small cap ($468M) but forecasts stack cleanly. |
| 12 | CALX | BUY PULLBACK | 6.4 | 1d fc +20/+24/+15% and 1d pos_in_range 100 — chase risk; buy near $36. |
| 13 | SRAD | BUY PULLBACK | 6.2 | PEG 0.47 and 69.61% EPS growth but 1wk forecasts all negative (-9/-24/-14). |
| 14 | MSFT | BUY PULLBACK | 6.1 | Blue-chip base but near_term_bullish only 0.2, 1h/4h at pos 100, Xbox layoffs headline is mild negative. |
| 15 | NOW | BUY PULLBACK | 6.0 | 1d fc_mid +38.49%, defense/AI wins, but 1h/4h at pos 100 and fwdPe 21.33 leaves less margin. |
| 16 | WK | BUY PULLBACK | 5.9 | PE 223 is optics-ugly but PEG 0.41; 1wk fc_mid +70%, though near_term_bullish is 0.2. |
| 17 | SMCI | WAIT | 5.7 | 1d fc_mid +44% but weekly dd -42.24%, recom 3.0 (hold), short float 17.27% — needs structural repair. |
| 18 | SAP | WAIT | 5.6 | Solid fundamentals but analyst fair value falling and AI monetization still unproven per 7/3 note. |
| 19 | GDYN | BUY PULLBACK | 5.4 | 1wk fc_mid +154% eye-popping but SeekingAlpha downgrade (6/22) and operMargin 0.19% — speculative. |
| 20 | INTR | BUY PULLBACK | 5.3 | PEG 0.23 and 50% sales growth, but 1wk forecasts all negative — wait for weekly stabilization. |
| 21 | MLCO | BUY PULLBACK | 5.1 | PEG 0.23 and 1wk fc +20/+51/+43%, but Morgan Stanley downgrade to Equal-Weight caps upside. |
| 22 | TOST | WAIT | 4.9 | RSI 69.45 and 1h fc all deeply negative (-3, -15, -14) — extended into resistance. |
| 23 | AVPT | WAIT | 4.7 | RSI 69.95, 1h fc -7/-16/-12, 1wk fc all negative — momentum exhaustion. |
| 24 | FRSH | WAIT | 4.6 | Short-term forecasts negative across 1h/4h and recom 2.07 — no near-term edge. |
| 25 | UWMC | WAIT | 4.4 | Debt/eq 70.65 is a red flag; price target cut 13.3% on 6/30 offset by KBW upgrade — mixed signals. |
| 26 | BX | WAIT | 4.3 | Expected return only 22.5%, 1h fc long -8%, targetUpside only 15.4% — better setups elsewhere. |
| 27 | CEG | WAIT | 4.1 | RSI 39, 1wk fc +30% but 1d dd -30% and Citi Neutral — no near-term catalyst. |
| 28 | CRK | AVOID | 3.6 | Goldman Sell reiterated 7/6 with $10 PT (current $14.32); Morgan Stanley also cut PT; short float 30.49%. |
| 29 | FUTU | AVOID | 3.2 | DOJ probe and US class actions (7/3) — regulatory landmine overrides the strong fundamentals. |
| 30 | PODD | AVOID | 3.0 | FDA classified Omnipod recall as Serious after injury reports (7/6) — do not step in front of that. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord